Clinical Trial Update: The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients [Phase 3]

View source ↗

Summary

Phase 3 trial results were posted evaluating the vascular effects of carvedilol controlled-release in abdominally obese hypertensive patients; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Obesity
• Hypertension

Drugs mentioned

• Carvedilol CR (carvedilol)

Snippet

Sponsor: St. Paul Heart Clinic | Conditions: Abdominal Obesity, Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-11-08